Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004421 · ClinicalTrials.gov registry record · Phase 2
Deep Brain Stimulation in Treating Patients With Dystonia
A Phase 2 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT00004421 is a Phase 2 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 15 participants.
The verdict
NCT00004421, a Phase 2 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
RATIONALE: Dystonia is a disorder in which the muscles that control voluntary movements are persistently or intermittently contracted (not relaxed). Deep brain stimulation is provided by a small, battery operated implant placed under the skin of the chest that delivers low voltage electrical pulses through a wire under the skin that is connected to a specific area of the brain. Deep brain stimulation may help lessen the symptoms of dystonia. PURPOSE: Phase II/III trial to study the effectiveness of deep brain stimulation in treating patients who have dystonia.
Interventions
- DEVICE implanted pulse generator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 1997-09 |
| Est. Completion | 2000-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004421
The ClinicalTrials.gov registry entry for NCT00004421 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which implanted pulse generator is the first listed.
NCT00004421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004421 about?
NCT00004421 is a clinical study titled "Deep Brain Stimulation in Treating Patients With Dystonia". RATIONALE: Dystonia is a disorder in which the muscles that control voluntary movements are persistently or intermittently contracted (not relaxed). Deep brain stimulation is provided by a small, battery operated implant placed under the skin of the chest that delivers low voltage electrical pulses ...
What is the current status of trial NCT00004421?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 1997-09. Estimated completion is 2000-09.
What interventions are being tested in trial NCT00004421?
The interventions under investigation include: implanted pulse generator (DEVICE).
Who is sponsoring clinical trial NCT00004421?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.